Rheumatoid arthritis - change, recommencement or demonstration of response authority application form (PB247)

Use this form to apply to change or recommence PBS-subsidised treatment with the originator brand of a biological agent for adult patients with severe active rheumatoid arthritis.

You must download our forms and fill them in so they are processed quickly. You can also electronically sign some of our forms. We have help available if you use assistive technology.

You can upload this form in HPOS.

You can use this form for patients reclassified from paediatric severe active juvenile idiopathic arthritis or systemic juvenile idiopathic arthritis.

You can also use this form to submit a demonstration of response to the current PBS-subsidised treatment.

‘Biological agent’ refers to:

  • abatacept
  • adalimumab
  • baricitinib
  • certolizumab
  • etanercept
  • golimumab
  • infliximab
  • tocilizumab
  • tofacitinib
  • upadacitinib.

Download and complete the rheumatoid arthritis - change, recommencement or demonstration of response authority application form.

Page last updated: 1 May 2024.
QC 46521